Benign recurrent intrahepatic cholestasis: Review and long-term follow-up of five cases

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 482-488

  Folvik, Geir ^a   Hilde, Olset ^b   Helge, Gilja Odd ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

BRIC; intrahepatic cholestasis; jaundice; plasmapheresis; pruritus; rifampicin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLASE; ANTIHISTAMINIC AGENT; BILIRUBIN; COLESTYRAMINE; CREATININE; ERYTHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS A VACCINE; PREDNISOLONE; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ACUTE PANCREATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE DURATION; DRUG WITHDRAWAL; DUODENAL ULCER BLEEDING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGASTRIC PAIN; FATIGUE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE MUTATION; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; INTRAHEPATIC CHOLESTASIS; JAUNDICE; KIDNEY FAILURE; LIVER BIOPSY; MALE; OBSTRUCTIVE JAUNDICE; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; REMISSION; SEPTICEMIA; SIDE EFFECT; TOXIC HEPATITIS; TREATMENT FAILURE; TREATMENT WITHDRAWAL; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; BILIRUBIN; CHOLESTASIS, INTRAHEPATIC; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLASMAPHERESIS; RECURRENCE; RIFAMPIN; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID; YOUNG ADULT;

EID: 84858652977     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.650191     Document Type: Article

References (16)

1. van der Woerd WL, van Mil SWC, Stapelbroek JM, Klomp LWJ, van de Graaf SFJ, Houwen RHJ. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol 2010;24:541-53.
2. Summerskill WHJ, Walsh JM. Benign recurrent intrahepatic obstructive jaundice. Lancet 1959;2:686-90.
3. Tygstrup N, Jensen B. Intermittent intrahepatic cholestasis of unknown aetiology in five young males from the Faroe Islands. Acta med Scand 1969;185:523-30.
4. Houwen RH, Baharloo S, Blankenship K, Raeymakers P, Juyn J, Sandkuijl LA, et al. Genome screening by searching for shared segments: mapping of a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380-6. (Pubitemid 24375605)
5. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-24. (Pubitemid 28117258)
6. Stapelbroek JM, van Erpecum KJ, Klomp LWJ, Houwen RHJ. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010;52:258-71.
7. Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, van Eijk MJ, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27-38. (Pubitemid 38868920)
8. Kubitz R, Keitel V, Haussinger D. Inborn errors of biliary canalicular transport systems. Methods Enzymol 2005;400:558-69. (Pubitemid 43052440)
9. Elferink RPJO, Paulusma CC, Groen AK. Hepatocanalicular transport defects: patophysiologic mechanisms of rare diseases. Gastroenterology 2006;130:908-25. (Pubitemid 43374538)
10. Saich R, Collins P, Ala A, Standish R, Hodgson H. Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. Eur J Gastroenterol Hepatol 2005;17:585-8. (Pubitemid 40592719)
11. Arulprakash S, Babu PI, Pugazhendhi T, Jeevankumar S. Benign Recurrent Intrahepatic Cholestasis (BRIC). The internet. J Paediatr Neonatol 2009;9.
12. Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology 1991;13:1076-83.
13. Cancado EL, Leitao RM, Carrilho FJ, Laudanna AA. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpepsidase. Am J Gastroenterol 1998;93:1510-17. (Pubitemid 29075191)
14. Kumagi T, Heathcote EJ. Successfully treated intractable pruritus with rifampicin in a case of benign recurrent intrahepatic cholestasis. Clin J Gastroenterol 2008;1:160-3.
15. Sanderson F, Quaranta JF, Cassuto-Viguier E, Grimaldi C, Troin D, Dujardin P, et al. The value of plasma exchange during flare-ups of benign recurrent intrahepatic cholestasis. Ann Med Interne (Paris) 1988;139:35-7. (Pubitemid 19039570)
16. Bircher J. Correspondence: treatment of patients with Benign Recurrent Intrahepatic Cholestasis. Hepatology 1989;10:1030-3.